ENGLEWOOD, Colo., Aug. 15 The "Overview of USP 797"technical paper, authored by Baxa Corporation's Mike Hurst, RPh, MBA, is nowavailable at http://expert411.com/_wsn/page3.html for media and professionalaccess. Most hospital pharmacists simply want to comply with the basicrequirements of USP 797 and get on with the business of patient care. Thispaper is intended to help pharmacies get started in that direction. It alsodiscusses USP 797 from several unique angles not necessarily considered in theinitial literature published on the subject.
This technical paper and links to eight other related publications are nowavailable along with Hurst's Expert Profile information at the Expert411.comsite. Other topics include:
Hurst worked for 18 years at Swedish Medical Center in Seattle, Washingtonin operational management, including positions as IV Supervisor and AssistantDirector of Pharmacy. His implementation of a syringe infusion system in 1984had national implications. For the next nine years Hurst wrote, spoke,consulted and acted as a reference site for syringe infusion installationsacross the country.
Moving to industry full time in 1994, Hurst joined Baxa Corporation asVice President of Infusion Systems. His job duties have included customersupport for syringe infusion system installations, new business and productdevelopment roles, and professional services support for various Baxa pharmacyand nursing product lines. Hurst is currently consulting with a hospitalsystem in the development of a comprehensive USP 797 compliance template thatcan be applied in other hospital pharmacies.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative,solution-based technologies for fluid handling and delivery. Its systems anddevices promote the safe and efficient preparation, handling, packaging, andadministration of fluid medications. Key products include Rapid-Fill(TM)Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) SyringeInfusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM)Multi-Source Automated Compounders; used worldwide in hospitals and healthcarefacilities. Privately held, Baxa Corporation has subsidiaries and salesoffices in Canada and the United Kingdom; direct representation in Austria,Belgium, Finland, France, Germany, Luxembourg, The Netherlands andSwitzerland; and distribution partners worldwide. Further information isavailable at http://www.baxa.com.-- Oral Medication Dispensers in Clinical Research -- Enteral Feeding Misconnections -- Environmental Controls for Sterile Compounding -- The Limitations of Isolators -- Pharmacy Considerations for Syringe Batch Processing -- Safe Handling of Hazardous Drugs -- USP 797 Requirements for Automated Compounders -- Risk Level Assessment of Compounded Sterile Preparations
SOURCE Baxa Corporation